PAOLO PRANDONI

Cenni Biografici
Laurea in Medicina e Chirurgia presso l’Università degli Studi di Padova con il punteggio di 110/110 con lode nel 1971. Specializzazioni in “Ematologia Clinica e di Laboratori nel 1974. in “Medicina Interna nel 1976, in “Malattie dell’Apparato Cardiovascolari nel 1979. PhD (ottenuto all’Università di Amsterdam nel 1992): Contrattista Ministeriale dal 1974 al 1980. Ricercatore Universitario dal 1981 al 1999. Professore Associato dal 2000 al 2006. Professore Ordinario dal 2007 ad oggi. Direttore della Cattedra di Clinica Medica 2 dal 2011 al 2014 e della UOSD Coagulopatie dal 2014 ad oggi.
Coordinatore dei Corsi Integrati di Medicina Interna 1-2 per studenti del 5-6° corso di laurea di Medicina e Chirurgia. Docente di molti corsi per Scuole di Specializzazione. Presidente del Master di Medicina Vascolare. Vicedirettore del Dipartimento di Scienze Cardiovascolari e Toraciche dell’Università di Padova.
Dal 2017 riveste l’incarico di Presidente della Commissione Scientifica della Fondazione Arianna di Bologna.
Membro dell’American College of Chest Physicians, della International Society of Thrombosis and Haemostasis, della Mediterranean League against Thromboembolic Diseases, della Società Italiana di Emostasi e Trombosi, della Società Italiana di Patologia Vascolare.
Ha collaborato alle seguenti principali riviste e giornali: New England Journal of Medicine, Lancet, Ann Intern Med, Circulation, Blood, British Medical Journal, American Journal of Medicine, Journal of Thrombosis and Haemostasis, Thrombosis and Haemostasis, Haematologica
Ha pubblicato 18 Monografie; 29 Capitoli di libro; 635 pubblicazioni in extenso; 215 lavori in collaborazione; 86 proceedings in extenso di Congressi; 661 abstract di congressi; 36 traduzioni e varie. Citation index: 70030. D-Index: 109.

Campi di interesse
fisiopatologica, diagnosi, prevenzione e cura della malattia tromboembolica venosa e di altre cardiovasculopatie.

Elenco pubblicazioni scelte

Articoli su riviste
1. Prandoni P, Lensing AWA, Prins MH, Villalta S, Pesavento R, Tormene D, Noventa F, Palareti G. Elastic compression stockings for prevention of the post-thrombotic syndrome in patients with and without residual vein thrombosis and/or popliteal valve reflux. Haematologica 2022;107:303-6.
2. Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings CS, Jiménez D, Kucher N, Lang IM, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Ní Áinle F, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano JL; ESC Scientific Document Group.2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 2020;41:543-603.
3. Khan F, Rahman A, Carrier M, Kearon C, Weitz JI, Schulman S, Couturaud F, Eichinger S, Kyrle PA, Becattini C, Agnelli G, Brighton TA, Lensing AWA, Prins MH, Sabri E, Hutton B, Pinede L, Cushman M, Palareti G, Wells GA, Prandoni P, Büller HR, Rodger MA; MARVELOUS Collaborators. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis. BMJ 2019;366:l4363.
4. Weitz JI, Lensing AWA, Prins MH, Bauersachs R, Beyer-Westendorf J, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Freitas MCS, Holberg G, Kakkar AK, Haskell L, van Bellen B, Pap AF, Berkowitz SD, Verhamme P, Wells PS, Prandoni P; EINSTEIN CHOICE Investigators. Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism. N Engl J Med 2017;376:1211-22.
5. Prandoni P, Lensing AW, Prins MH, Ciammaichella M, Perlati M, Mumoli N, Bucherini E, Visonà A, Bova C, Imberti D, Campostrini S, Barbar S; PESIT Investigators.Prevalence of Pulmonary Embolism among Patients Hospitalized for Syncope. N Engl J Med 2016;375:1524-31.
6. Kahn SR, Comerota AJ, Cushman M, Evans NS, Ginsberg JS, Goldenberg NA, Gupta DK, Prandoni P, Vedantham S, Walsh ME, Weitz JI; on behalf of the American Heart Association Council on Peripheral Vascular Disease, Council on Clinical Cardiology, and Council on Cardiovascular and Stroke Nursing. The Postthrombotic Syndrome: Evidence-Based Prevention, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. Circulation 2014;130:1636-61.
7. Simes J, Becattini C, Agnelli G, Eikelboom JW, Kirby AC, Mister R, Prandoni P, Brighton TA; for the INSPIRE (International Collaboration of Aspirin Trials for Recurrent Venous Thromboembolism) Study Investigators. Aspirin for the Prevention of Recurrent Venous Thromboembolism: The INSPIRE Collaboration. Circulation 2014;130:1062-71.
8. Palareti G, Cosmi B, Legnani C, Antonucci E, De Micheli V, Ghirarduzzi A, Poli D, Testa S, Tosetto A, Pengo V, Prandoni P. D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study. Blood 2014;124:196-203.
9. Pesavento R, Filippi L, Pagnan A, Visonà A, Pauletto P, Vescovo G, Cuppini S, Beltramello G, Villalta S, De Conti G, Vedovetto V, Frigo AC, Prandoni P; PROVE Investigators Group. Unexpectedly high recanalization rate in patients with pulmonary embolism treated with anticoagulants alone. Am J Respir Crit Care Med 2014;189:1277-1279
10. Prandoni P. Venous thromboembolism in 2013: The advent of the novel oral anticoagulants. Nat Rev Cardiol 2014;11:70-2.
11. Leizorovicz A, Becker F, Buchmüller A, Quéré I, Prandoni P, Decousus H. Clinical relevance of symptomatic superficial-vein thrombosis extension: lessons from the CALISTO study. Blood 2013;122:1724-9.
12. Prandoni P. Peripherally inserted catheters: all that glitters is not gold. Lancet 2013; 382:288-90.
13. Becattini C, Agnelli G, Schenone A, Eichinger E, Bucherini E, Silingardi M, Bianchi M, Moia M, Ageno W, Vandelli MR, Grandone E, Prandoni P. Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med 2012;366:1959-1967.
14. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR. Antithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012 141(2 Suppl): 419S-94S.
15. Prandoni P, Noventa F, Quintavalla R, Bova C, Cosmi B, Siragusa S, Bucherini E, Astorri F, Cuppini S, Dalla Valle F, Lensing AW, Prins MH, Villalta S. Thigh-length versus below-knee compression elastic stockings for prevention of the post-thrombotic syndrome in patients with proximal-venous thrombosis: a randomized trial. Blood 2012;119 1561-5.
16. Sørensen HT, Horvath-Puho E, Lash TL, Christiansen CF, Pesavento R, Pedersen L, Baron JA, Prandoni P. Heart Disease May Be a Risk Factor for Pulmonary Embolism Without Peripheral Deep Venous Thrombosis. Circulation 2011;124:1435-41.
17. Prandoni P, Casiglia E, Tikhonoff V, Leizorovicz A, Decousus H. The risk of subsequent cancer and arterial cardiovascular events in patients with superficial vein thrombosis in the legs. Blood 2011;118:4719-22.
18. Pengo V, Noventa F, Denas G, Pengo MF, Gallo U, Grion AM, Iliceto S, Prandoni P. Long-term use of vitamin K antagonists and incidence of cancer: a population-based study. Blood 2011;117:707-9.
19. Decousus H, Prandoni P, Mismetti P, Bauersachs RM, Boda Z, Brenner B, Laporte S, Matyas L, Middeldorp S, Sokurenko G, Leizorovicz A. Fondaparinux for the Treatment of Superficial-Vein Thrombosis in the Legs. N Engl J Med 2010;363:1222-32.
20. Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, De Bon E, Tormene D, Pagnan A, Prandoni P. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: The Padua Prediction Score. J Thromb Haemost 2010;8:2450-7.